FROM: CENTERS FOR DISEASE CONTROL AND PREVENTION
Zinc Deficiency–Associated Dermatitis in Infants During a Nationwide Shortage of Injectable Zinc — Washington, DC, and Houston, Texas, 2012–2013
Duke J. Ruktanonchai, M.D.
Lieutenant Commander, U.S. Public Health Service
CDC Epidemic Intelligence Service Officer
Texas Department of State Health Services
During national shortages of injectable zinc, hospitals should consider reserving supplies for infants at highest risk for deficiency. Injectable zinc, a vital component of parenteral nutrition (PN) formulations, was reported to be in short supply in 2012. Early reports resulted in the publication of a MMWR notice regarding the shortage and early reports of problems in premature infants. Premature and low birth weight (LBW) infants are especially vulnerable to micronutrient deficiencies. This report discusses investigation into the effects of the shortage on a group of premature infants in two states. Through collaboration of CDC, FDA, the American Academy of Pediatrics, hospitals, and clinicians, public health actions were taken to prevent zinc deficiency disorders in vulnerable infants during the shortage.